Combining Business and Clinical Development Strategies with
Anne Altmeyer, PhD, MBA, MPH VP, Business Development & Licensing, Head Negotiations, Oncology, Baxalta Robert Ang, MD, MBA Chief Business Officer, Neon Therapeutics Jeffrey Bockman, PhD Vice President, Defined Health Philippe Lopes-Fernandes SVP and Head of Global Licensing & Business Development, Merck KGaA Michael King Jr
2012 CABA Investment Innovation Entrepreneurship Symposium
Anne Altmeyer, Ph D , MBA, MPH – Keynote Speaker VP, BD and Licensing, Oncology Business Unit at Novartis, USA Presentation Title: Novartis Oncology Licensing Strategy & Process Anne Altmeyer is the Vice President of Business Development and Licensing in the Oncology Business Unit at Novartis, USA Her responsibilities include in-
Immunity, Vol 7, 667–677, November, 1997, Copyright 1997 by
Anne Altmeyer,* Rosalind C Simmons,* Stanislaw Krajewski,† John C Reed,† Ge W Bornkamm,‡ and Selina Chen-Kiang*§ *Departments of Pathology and Microbiology Cornell University Medical College New York, New York 10021 ing, virtually nothing is known about the signals and †The Burnham Institute
SPEAKERS 2nd Annual Sachs Immuno-Oncology: BD&L and
Anne Altmeyer, VP Business Development, Negotiations, Baxalta, Inc Anne has about 20 years of experience in the Pharmaceutical Industry working in positions of increasing responsibilities in Research, Development, and Business Development Since September 2015, Anne Altmeyer is a Vice President Business Development & Licensing at Baxalta
SPEAKERS 3rd Annual Sachs Cancer Bio Partnering & Investment
Anne Altmeyer, VP, Business Development, Head Negotiation, Oncology, Novartis Pharmaceuticals Anne Altmeyer is Vice President, Head Global Negotiations in Business Development & Licensing (BD&L) in the Oncology Business Unit at Novartis In this capacity, her responsibilities are to in-license or acquire Oncology assets that can further
EUROPEAN LIFE SCIENCE CEO FORUM
Anne Altmeyer, VP, Business Development, Head Negotiation, Oncology, Novartis Pharmaceuticals Anne Altmeyer is Vice President, Head Global Negotiations in Business Development & Licensing (BD&L) in the Oncology Business Unit at Novartis In this capacity, her responsibilities are to in-license or acquire Oncology assets that can further
TRAIL/Apo-2 Ligand Induces Primary Plasma Cell Apoptosis
TRAIL/Apo-2 Ligand Induces Primary Plasma Cell Apoptosis1 Josie Ursini-Siegel,* Wenli Zhang,* Anne Altmeyer,* Eunice N Hatada,* Richard K G Do,*
1998 MINNESOTA PGA-MGA GOLF HALL OF FAME
Please list accomplishments and awards of the individual that you are nominating for the MINNESOTA PGA-MGA GOLF HALL OF FAME
[PDF] Anne Baudart - Festival
[PDF] Anne Bertrand, la chute est un commencement - Céline Vaché - Art Et De Divertissement
[PDF] Anne Beyaert Pierre Boudon Raoul Coutard Jean
[PDF] Anne BOLLINGER - Anciens Et Réunions
[PDF] Anne Bonny, journal intime - Sexe
[PDF] Anne BOSSÉ - Université François Rabelais
[PDF] Anne Boudeau / Toute l`année - Tél - France
[PDF] Anne Boussarie nommée Directrice Générale de Getty Images France
[PDF] Anne Bragance pdf
[PDF] Anne Burkhalter, 3, rue de la Chapelle, 1860 Aigle, 024/466 55 14
[PDF] Anne Carole Immobilier et Plan - Gestion De Projet
[PDF] Anne cécile Deliaud : Danse, texte Pierre Diaz : Musique, texte
[PDF] Anne Collier (1970-) - FRAC Nord - France
[PDF] Anne Collot - Mouvaux avec vous